Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    -10.00 (-0.43%)
Bid:
2,320.00
Ask:
2,325.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 Apr 2025 07:00

RNS Number : 3563F
RIT Capital Partners PLC
17 April 2025
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

17 April 2025

Monthly Valuation Update and Factsheet

RIT Capital Partners plc ("RIT" or the "Company") announces that its unaudited diluted NAV at 31 March 2025 (with debt at fair value) was 2,599p per £1 ordinary share (28 February 2025: 2,689p), -3.4% from the previous month, outperforming the ACWI (50% £), which was down -5.3%. Q1 NAV per share total return was -0.6%, outperforming the ACWI (50% £), which was -3.1%.

RIT's Factsheet, which includes performance highlights and commentary for the month of March 2025, is available via this link:

https://www.ritcap.com/wp-content/uploads/2025/04/RIT_Factsheet_march_2025.pdf

 

Portfolio update - Webull Corporation

One of the Company's private investments - Webull - a digital investment platform, merged with SK Growth Opportunities Corp, a Special Purpose Acquisition Company ("SPAC"), and commenced trading on the Nasdaq stock exchange under the ticker symbol: BULL on 11 April 2025. The Company's 31 December 2024 valuation of Webull was $64m (£50m). Following a restructuring of our investment in Webull for the purposes of the SPAC merger, our investment now includes listed Class A ordinary shares as well as other positions in Webull's capital structure. The estimated value of our entire position in Webull at the closing price on 11 April 2025 of $13.25 per Class A ordinary share, was approximately $121m or £93m of which around $106m or £81m was in ordinary shares. Along with other pre-merger shareholders, we are subject to customary lock-up provisions. We note that while these lock-up provisions are in place, a limited number of shares are available to trade, which can result in higher stock volatility.

 

An updated valuation for Webull will be reflected in the 30 April 2025 NAV which will be released to shareholders in mid-May as normal.

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Deutsche Numis (Joint broker):

Nathan Brown, Vicki Paine

T: 020 7260 1000

 

JP Morgan Cazenove (Joint broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group (Media enquiries):

Nick Cosgrove, Sofie Brewis

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQQLFFEZLLBBV
Date   Source Headline
12th Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20229:45 amRNSBoard Appointments
2nd Aug 20227:00 amRNSHalf-year Report
20th Jul 20227:00 amRNSNet Asset Value(s)
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSNet Asset Value(s)
17th May 20227:00 amRNSNet Asset Value(s)
4th May 20224:51 pmRNSResult of AGM
27th Apr 20222:24 pmRNSDirector/PDMR Shareholding
26th Apr 20224:40 pmRNSBoard Appointment
19th Apr 20227:00 amRNSNet Asset Value(s)
14th Mar 20227:00 amRNSNet Asset Value(s)
1st Mar 20227:00 amRNSAnnual Financial Report
23rd Feb 20224:18 pmRNSHolding(s) in Company
22nd Feb 20222:45 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSNet Asset Value(s)
15th Feb 20224:26 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSNet Asset Value(s)
15th Dec 20217:00 amRNSNet Asset Value(s)
3rd Dec 20217:00 amRNSDirector Declaration
23rd Nov 20215:22 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSNet Asset Value(s)
4th Nov 20214:57 pmRNSBoard Announcements
15th Oct 20217:00 amRNSNet Asset Value(s)
15th Sep 20217:00 amRNSNet Asset Value(s)
16th Aug 20217:00 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSHalf-year Report
20th Jul 20217:00 amRNSNet Asset Value(s)
28th Jun 20216:17 pmRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSTransaction in Own Shares
22nd Jun 20217:00 amRNSTransaction in Own Shares
15th Jun 20217:00 amRNSNet Asset Value(s)
21st May 20215:15 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSNet Asset Value(s)
22nd Apr 20215:52 pmRNSResult of AGM
19th Apr 20217:00 amRNSNet Asset Value(s)
13th Apr 20214:17 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSDirector/PDMR Shareholding
24th Mar 20216:17 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSTransaction in Own Shares
12th Mar 20217:00 amRNSNet Asset Value(s)
11th Mar 20217:00 amRNSHolding(s) in Company
5th Mar 20219:38 amRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSAnnual Financial Report
26th Feb 20218:10 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSHolding(s) in Company
15th Feb 20217:00 amRNSNet Asset Value(s)
4th Feb 20217:00 amRNSNet Asset Value(s)
23rd Dec 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.